Forty-three cases of advanced pulmonary tuberculosis were treated for the first time for at least nine months of isoniazid to daily doses of 5 and 10 mg. per kl. In 36 cases the administration of isoniazid was extended to twelve months, and at 29, 15 and 21 months. In 34 cases kept under observation for two years, 83% were no longer infectious and 71% all cavities were closed. The analysis of these results provides clinical evidence to suggest that the therapeutic efficacy of the regimen with the drug isoniazid alone is not dissimilar to the therapeutic efficacy of isoniazid is streptomycin or isoniazid, PAS, and that should be investigated higher doses of isoniazid.Cuarenta y tres casos de tuberculosis pulmonar avanzada fueron tratados por...
controlled study of a year’s treatment, on an out-patient basis, with one of the following two ful...
Introducción: La tuberculosis (TB) sigue siendo uno de las principales causas de muerte en el mundo....
A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tube...
Objetivo. Elaborar esquemas de tratamiento para tuberculosis de acuerdo con sus perfiles de suscepti...
La tuberculosis sigue siendo una causa importante de mortalidad en el mundo entero
Objetivo. Elaborar esquemas de tratamiento para tuberculosis de acuerdo con sus perfiles de suscepti...
ResumenEl control de la tuberculosis exige nuevas pautas terapéuticas que superen las actuales, disp...
El control de la tuberculosis exige nuevas pautas terapéuticas que superen las actuales, disponibles...
An earlier report showed that, in patients with bacteriologically quiescent pulmonary tuberculosis a...
Objetivo: Analizar la eficacia de un programa específico para el estudio y seguimiento de los contac...
This report from the Tuberculosis Chemotherapy Centre, Madras, describes theprogress, over a 5-year...
The success of a twice-weekly fully supervised regimen of streptomycin plus high dosage isoniazid i...
Isoniazid mono-resistance (IMR) is the most common form of mono-resistance; its world prevalence is ...
A controlled clinical trial of 4 regimens was undertaken in patients with bacteriologically positiv...
Previous reports from the Tuberculosis Chemotherapy Centre, Madras, have described a comparison of ...
controlled study of a year’s treatment, on an out-patient basis, with one of the following two ful...
Introducción: La tuberculosis (TB) sigue siendo uno de las principales causas de muerte en el mundo....
A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tube...
Objetivo. Elaborar esquemas de tratamiento para tuberculosis de acuerdo con sus perfiles de suscepti...
La tuberculosis sigue siendo una causa importante de mortalidad en el mundo entero
Objetivo. Elaborar esquemas de tratamiento para tuberculosis de acuerdo con sus perfiles de suscepti...
ResumenEl control de la tuberculosis exige nuevas pautas terapéuticas que superen las actuales, disp...
El control de la tuberculosis exige nuevas pautas terapéuticas que superen las actuales, disponibles...
An earlier report showed that, in patients with bacteriologically quiescent pulmonary tuberculosis a...
Objetivo: Analizar la eficacia de un programa específico para el estudio y seguimiento de los contac...
This report from the Tuberculosis Chemotherapy Centre, Madras, describes theprogress, over a 5-year...
The success of a twice-weekly fully supervised regimen of streptomycin plus high dosage isoniazid i...
Isoniazid mono-resistance (IMR) is the most common form of mono-resistance; its world prevalence is ...
A controlled clinical trial of 4 regimens was undertaken in patients with bacteriologically positiv...
Previous reports from the Tuberculosis Chemotherapy Centre, Madras, have described a comparison of ...
controlled study of a year’s treatment, on an out-patient basis, with one of the following two ful...
Introducción: La tuberculosis (TB) sigue siendo uno de las principales causas de muerte en el mundo....
A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tube...